A Tumor-Homing Peptide Platform Enhances Drug Solubility, Improves Blood-Brain Barrier Permeability and Targets Glioblastoma.
Choi-Fong ChoCharlotte E FarquharColin M FadzenBenjamin ScottPei ZhuangNiklas von SpreckelsenAndrei LoasNina HartrampfBradley L PenteluteSean E LawlerPublished in: Cancers (2022)
BTP-7 is a new modality that opens the door to possibilities for GBM-targeted therapeutic approaches.